Pediatric non-hodgkin lymphoma: A retrospective 14-year experience with Berlin-Frankfurt-Mnster (BFM) protocols from a tertiary care hospital in Serbia

Pediatric Hematology and Oncology

Volumn 29, Issue 2, 2012, Pages 109-118

  Dokmanovic, Lidija ^a   Krstovski, Nada ^a   Vukanic, Dragan ^a   Brasanac, Dimitrije ^b   Rodic, Predrag ^a   Cvetkovic, Mirjana ^a   Janic, Dragana ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Non Hodgkin lymphoma; Pediatric; Serbia

Indexed keywords

ALLOPURINOL; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOXORUBICIN; ETOPOSIDE; FUROSEMIDE; MELPHALAN; PREDNISONE; RITUXIMAB; THIOTEPA; VINCRISTINE;

ADOLESCENT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL PROTOCOL; DRUG MEGADOSE; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SERBIA; TREATMENT OUTCOME; TUMOR LYSIS SYNDROME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; RETROSPECTIVE STUDIES; SERBIA; SURVIVAL RATE; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

EID: 84857874387     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2011.652342     Document Type: Article

References (31)

1. Atra A, Imeson JD, Hobson R, et al. Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol. Br J Cancer. 2000;82:1396-1402. (Pubitemid 30175904)
2. Burkhardt B, Zimmermann M, Oschlies I, et al. Te impact of age and gender on biology, clinical features and treatmentoutcome ofnon-Hodgkinlymphoma in childhood and adolescence.BrJHaema-tol. 2005;131:39-49. (Pubitemid 43899706)
3. Cairo MS, Krailo MD, Morse M, et al. Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report. Leukemia. 2002;16:594-600. (Pubitemid 34449739)
4. Eden OB, Hann I, Imeson J, et al. Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503. Br J Haematol. 1992;82:310-316.
5. Le Deley MC, Rosolen A, Williams DM, et al. Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial. J Clin Oncol. 2010;28:3987-3993.
6. Marky I, Bjork O, Forestier E, et al. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the Nordic Society of Pediatric Hematology and Oncology. J Pediatr Hematol Oncol. 2004;26:555-560. (Pubitemid 39223663)
7. Patte C, Auperin A, Gerrard M, et al. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood. 2007;109:2773-2780. (Pubitemid 46482070)
8. Reiter A, Schrappe M, Parwaresch R, et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratifed for biologic subtypes and stage-a report of the Berlin-Frankfurt-Münster Group. J Clin Oncol. 1995;13:359-372.
9. World Health Organization Classifcation of Tumors. In: Harris NL, Jafe ES, Vardiman JW, Stein H, Diebold J, Müller-Hermelink HK, Flandrin G. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001:10-14.
10. Reiter A. Diagnosis and treatment of childhood non-hodgkin lymphoma. Hematology Am Soc Hema-tol Educ Program. 2007:285-296.
11. Murphy SB. Classifcation, staging and end results of treatment of childhood non-Hodgkin's lym-phomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7:332-339. (Pubitemid 11228642)
12. Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classifcation. Br J Haematol. 2004;127:3-11. (Pubitemid 39331101)
13. Pession A, Masetti R, Rondelli R. Pediatric T-cell acute lymphoblastic leukemiaand T-cell lym-phoblastic lymphoma therapy. Hematol Meet Rep. 2009;3:111-114.
14. Seidemann K, Tiemann M, Lauterbach I, et al. Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group. J Clin Oncol. 2003;21:1782-1789. (Pubitemid 46638592)
15. 2: a single institution experience. Pediatr Blood Cancer. 2004;43:434.
16. Percy CL, Smith MA, Linet M, et al. Lymphomas and reticuloendothelial neoplasms. In: Ries LAG, Smith MA, Gurney JG, et al., eds. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. Bethesda: National Cancer Institute, SEER Program; 1999:35-50. NIH Publication No. 99-4649.
17. Baez F, Pillon M, Manfredini L, et al. Treatment of pediatric non-Hodgkin lymphomas in a country with limited resources: results of the frst national protocol in Nicaragua. Pediatr Blood Cancer. 2008;50:148-152. (Pubitemid 350234287)
18. Fadoo Z, Belgaumi A, Alam M, et al. Pediatric lymphoma: a 10-year experience at a tertiary care hospital in Pakistan. J Pediatr Hematol Oncol. 2010;32:e14-e18.
19. Moleti ML, Al-Hadad SA, Al-Jadiry MF, et al. Treatment of children with B-cell non-Hodgkin lym-phoma in a low-income country. Pediatr Blood Cancer. 2011;56:560-567.
20. Muller J, Csoka M, Jakab Z, et al. Treatment of pediatric non-Hodgkin lymphoma in Hungary: 15 years experience with NHL-BFM 90 and 95 protocols. Pediatr Blood Cancer. 2008;50:633-635. (Pubitemid 351155840)
21. Salzburg J, Burkhardt B, Zimmermann M, et al. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma difer by non-Hodgkin's lym-phoma subtype: a Berlin-Frankfurt-Münster Group Report. J Clin Oncol. 2007;25:3915-3922. (Pubitemid 47477269)
22. Bakshi NA, Ross CW, Finn WG, et al. ALK-positive anaplastic large cell lymphoma with primary bone involvement in children. Am J Clin Pathol. 2006;125:57-63. (Pubitemid 43089726)
23. Mounasamy V, Berns S, Azouz EM, et al. Anaplastic large cell lymphoma presenting as an epiphy-seal lytic lesion-a case report with clinico-pathologic correlation. Skeletal Radiol. 2006;35:619-623. (Pubitemid 43983970)
24. Kenkre VP, Stock W. Burkitt lymphoma/leukemia: improving prognosis. Clin Lymphoma Myeloma. 2009;9(Suppl 3):S231-S238.
25. Wossmann W, Schrappe M, Meyer U, et al. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase. Ann Hematol. 2003;82:160-165. (Pubitemid 36700996)
26. Mann G, Attarbaschi A, Steiner M, et al. Early and reliable diagnosis of non-Hodgkin lymphoma in childhood and adolescence: contribution of cytomorphology and fow cytometric immunopheno-typing. Pediatr Hematol Oncol. 2006;23:167-176. (Pubitemid 43361799)
27. Chantada G, Casak S, Alderete D, et al. Treatment of B-cell malignancies in children with a modifed BFM-NHL 90 protocol in Argentina. Med Pediatr Oncol. 2003;41:488-490. (Pubitemid 37229453)
28. Kent EE, Morris RA, Largent JA, et al. Socioeconomic impacts on survival difer by race/ethnicity among adolescents and youngadults with non-Hodgkin's lymphoma. JCancerEpidemiol.2010;2010, 10 pages, doi:10.1155/2010/824691.
29. Pinkerton R, Wills RA, Coory MD, Fraser CJ. Survival from haematological malignancy in childhood, adolescence and young adulthood in Australia: is the age-related gap narrowing? Med J Aust. 2010;193:217-221.
30. Pillon M, Di Tullio MT,Garaventa A, et al.Long-termresults of the frst ItalianAssociation of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92). Cancer. 2004;101:385-394. (Pubitemid 38890844)
31. Pillon M, Piglione M, Garaventa A, et al. Long-term results of AIEOP LNH-92 protocol for the treatment of pediatric lymphoblastic lymphoma: a report of the Italian Association of Pediatric Hematol-ogy and Oncology. Pediatr Blood Cancer. 2009;53:953-959.